Kouki Shinohara
Chiyoda, 1010062, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Naphthalen-1-ylethanamine-containing small molecule inhibitors of the papain-like protease of SARS-CoV-2.
Journal: European journal of medicinal chemistry
Published: September 17, 2024
Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.
Journal: Chemical & pharmaceutical bulletin
Published: January 03, 2024
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement.
Journal: Chemical & pharmaceutical bulletin
Published: December 03, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties.
Journal: Journal of medicinal chemistry
Published: September 27, 2023
Development of anti-HBV agents targeting HBV capsid proteins.
Journal: RSC medicinal chemistry
Published: June 02, 2023
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2.
Journal: RSC advances
Published: November 19, 2022
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins.
Journal: RSC advances
Published: October 29, 2022
Potent and biostable inhibitors of the main protease of SARS-CoV-2.
Journal: iScience
Published: August 03, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026